myQA® PROactive

Unlock the power of risk analysis and transform it into value!

With myQA PROactive, you will:

  • Achieve higher safety levels
  • Perform objective risk evaluation
  • Strengthen compliance and follow best practice, efficiently

 

Contact us for your individual solution!
Begin Benefit

In the past, performing efficient risk analysis in a clinical setting was challenging.
With myQA® PROactive, you can now:

Ensure compliance and best practice

  • Align with key risk analysis guidelines, including AAPM TG 100 and European regulation 2013/59/EURATOM.

  • Start with fully editable, high-quality templates.

  • Evaluate risks using RPN and customizable risk matrices.

  • Generate customizable reports.

Enhance efficiency

  • Seamlessly import your existing FMEA Excel1 studies.

  • Facilitate team discussions with a user-friendly flowchart workflow description.

  • Maintain version control and electronic releases for ongoing risk analyses.

  • Focus on critical risks and explore failure causation chains with FTA risk analysis (automatically synchronized with FMEA).

  • Standardize risk management procedures across all relevant departments (RT, PT, nuclear medicine, etc.)


The only tool validating your risk analysis with real incidents

Implement a comprehensive risk management system you trust. It is finally possible to validate risk analysis predictions with reported incidents*. myQA® PROactive allows you to:

  • Assess risks using "expected rate of adverse events."
  • Easily report incidents from any device on your network.
  • Analyze incidents in line with your policies, using customizable forms.
  • Identify root causes and missing failure modes through “root cause analysis.”
  • Compare predicted and reported rates of adverse events and near misses.
  • Adjust risk evaluation and achieve complete consistency between prospective and retrospective data.
  • Evaluate safety measures based on the reduction in adverse event rates.
  • Conduct a cost/benefit analysis of your improvement plan.

 



test

myQA PROactive: The only commercial prospective risk management solution for radiation oncology, a tool for risk management.

David Menichelli from IBA Dosimetry talks about myQA PROactive.

David Menichelli

IBA Dosimetry 

6 min. (open access preview)47 min. (full presentation, members)

Proactive Risk Management in Radiation Oncology: from Burden to Value

Multi-professional healthcare teams use proactive risk management (RM) to analyse probable patient treatment failures and execute "safety measures" to prevent mishaps. IBA Dosimetry software for proactive risk management is myQA Proactive. This article shows how it solves FMEA spreadsheet flaws and facilitates AAPM TG100 [1] implementation so every clinic may manage risks with a positive effort balance.

Download the article


"myQA PROactive is an innovative tool for prospective risk analysis tailored to the needs of radiation oncology. It offers a formalized approach to risk assessment following best practice methodology. The software includes flowcharts and FMEA, and the integrated fault tree analysis identifies measures to block multiple error pathways, further increasing patient safety."

Prof. Dr. rer. nat. Christoph Bert, Head of Medical Physics, Erlangen University Hospital


Additional services

Training & coaching program

With IBA Dosimetry training and coaching you can become a myQA PROactive expert, fast. Learn risk analysis best practice and team moderation with your team in an efficient 2-day online training. Contact us for schedules and affordable pricing.


Clinical References

Explore more

  • Discover how the utilization of myQA PROactive facilitated efficient performance of a risk analysis for SGRT, ensuring the integrity of risk assessment and enabling comparison of alternative measures for risk reduction.
    S. Russo, M. Esposito, A. Bruschi, A. Ghirelli, P. Alpi , S. Scoccianti, “FMEA risk analysis of surface-guided DIBH breast radiotherapy by using a commercial software tool,” ESTRO 2023, 12-16 May 2023 Vienna, digital poster (session 6030: quality assurance and auditing).
    Read more
     
  • Discover how myQA PROactive allows users to effectively meet German regulatory requirements for conducting risk analysis in radiation therapy.
    D. Kornek, "myQA PROactive Risikomanagement: Von der Last zum Mehrwert," 53. Jahrestagung der Deutschen Gesellschaft für Medizinische Physik, Aachen, 22 Sept. 2022.
    Read more
     
  • Discover how the myQA PROactive enhances proactive risk management within a clinical environment.
    D. Menichelli, "myQA PROactive: A prospective risk management tool optimized for radiation oncology," BHPA 2023 annual symposium, 10-11 Feb. 2023 Brussels.
    Read more
     
  • Learn how myQA PROactive assists in meeting the regulatory requirements for internally developed software (MDR 2017/745 and IEC 62304).
    D. Dechambre, “Impact of the new medical device regulation on quality management”, myQA PROactive users’ workshop, Louvain-la-Neuve, 17 April 2023.
    Read more
     
  • Read how UZ Leuven streamlined a multifaceted risk management process that relied on several tools (Visio, Excel, Word) using myQA PROactive.
    C. Benazzouz, “Our experience from using Excel to using myQA PROactive,” myQA PROactive users’ workshop, Louvain-la-Neuve, 17 April 2023.
    Read more

  • Discover how the innovative features of myQA PROactive enable the validation of risk analysis using retrospective incident data.
    D. Kornek, D. Menichelli, J. Leske, R. Fietkau, C. Bert, „Iterative Approach to Improve Failure Modes and Effects Analysis through Feedback Systems”, AAPM 2023, July 23-27, Houston (TX).

     

  • Discover the advantages of using myQA PROactive instead of Excel as the tool for proactive risk management in radiation therapy, and understand the significance of utilizing risk analysis templates.
    S. Russo, “Implementation of proactive risk analysis in radiotherapy with myQA® PROactive. Case study: surface guided DIBH breast radiotherapy,” ESTRO 2023, 12-16 May 2023, Vienna.
    Read more

  • Learn the advantages of adopting myQA PROactive instead of relying on Excel for HFMEA workflow in a hospital that regularly conducts risk assessments for healthcare procedures
    N. Linthout, “From Excel-based HFMEA towards myQA PROactive”, ESTRO 2023, 12-16 May 2023, Vienna.
    Read more
     

  • Explore the profound ramifications of cybersecurity risks in the healthcare sector, encompassing threats, precautionary measures, and the pivotal function of cybersecurity risk management.
    Lämmerzahl, “Cybersecurity for medical devices: standardization of medical device cyber security”, myQA PROactive users’ workshop, Louvain-la-Neuve, 17 April 2023.
    Read more
     
  • Discover how the implementation of proactive risk management empowers hospitals to effectively handle uncertainties in projects such as the installation of new equipment, refurbishments, and department relocations.
    A. Batamuriza-Almasi, “The culture of conducting risk analysis for hospital projects and its impact on the healthcare environment,” myQA PROactive users’ workshop, Louvain-la-Neuve, 17 April 2023.
    Read more

  • Explore the potential risk management prerequisites for European radiotherapy clinics as they pertain to the national integration of EURATOM 2013/59 along with ISO 9001, the existing guidelines, and the obstacles that can be addressed through an electronic risk management platform.
    C. Rodriguez, “The hitchhiker’s guide to risk analysis,” myQA PROactive users’ workshop, Louvain-la-Neuve, 17 April 2023.
    Read more

  • Discover the current utilization of myQA PROactive in a multicenter study exploring the risks involved in diagnostic and therapeutic applications of nuclear medicine.
    R. Matheoud, L. Strigari, “Valutazione del rischio in Medicina Nucleare,” 12o Congresso Nazionale AIFM, 8-11 June 2023, Florence
    Read more

  • Discover how the innovative features of myQA PROactive enable the validation of risk analysis using retrospective incident data.
    D. Kornek, D. Menichelli, J. Leske, R. Fietkau, C. Bert, „Iterative Approach to Improve Failure Modes and Effects Analysis through Feedback Systems”, AAPM 2023, July 23-27, Houston (TX).
    Read more

End Benefit

Technical specs

Specifications - General

Deployment

On-premise hosting with Kestrel web server

Access

Web browser based; multiple users; multiple “departments*”

Data I/O

xls, xml, pdf, json

Specifications - Risk analysis

Risk analysis techniquesFMEA & FTA (automatically synchronized)
Process descriptionList & Flow chart (automatically synchronized)
Risk evaluationRisk matrix, RPN, expected rate of adverse events
Decision toolsCost/benefit analysis; mitigation scenarios
UI languageCustomizable
Version controlMultiple versions for any risk analysis; electronic release

Specifications - Retrospective module*

Incident reportingReporting terminals; application UI; xls
WarningsVia email
Incident documentationRoot cause analysis; customizable forms
Risk analysis validationComparison of expected and reported adverse events and near misses on failure mode basis

1. Windows 10, Windows Server 2016, and Edge are trademarks of the Microsoft group of companies.
2. Firefox is a trademark of the Mozilla Foundation in the U.S. and other countries.
* Release pending

System requirements

Installation machine

PC (single user)
Server (single and multiple users)

Operating system

Windows 10 1 or newer
Windows Server 2016 1 or newer

Minimum CPU power

2x2.0 GHz

Minimum available RAM

8GB

Minimum free disk space

4GB

Minimum screen resolution

1650 x 1050

Supported browsers

Edge1, Chrome™, and Firefox2
Supported databasesSQLite, Microsoft SQL Server* (2016 or newer)

* Release pending